Enzyme vs Vana — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Vana trades at Rp22,214 (market cap Rp627,53M, Rp20,83M 24h volume). The key difference: Vana is far larger — about 4.7× Enzyme's market cap, and Vana's supply is capped (30,1M / 120M VANA (26%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Vana for 7 Days on average.
| MLN | VANA | |
|---|---|---|
Market Cap | Rp134,13M | Rp627,53M |
Volume (24h) | Rp104,56M | Rp20,83M |
Circulating Supply | 3,3M MLN | 30,1M / 120M VANA (26%) |
Typical Hold Time | 28 Days | 7 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
VANA is trading at Rp22,356 with a market cap of Rp627.53 million, showing bullish technical signals with strong moving average support. The token has only 26% of its maximum 120 million supply in circulation, with relatively short 7-day average hold time indicating active trading. Technical indicators show bullish momentum with ADX signaling strong trend strength while RSI remains in neutral territory.
Overall outlook is cautiously optimistic with strong technical momentum but limited fundamental developments. Key opportunities include potential price appreciation from current support levels, while major risks include low liquidity and the token's early adoption phase with limited ecosystem activity.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Vana ($VANA) is an EVM-compatible Layer 1 blockchain that transforms personal data into tradable financial assets. It empowers users to securely monetize their private data through Data DAOs (Decentralized Autonomous Organizations) and innovative mechanisms like Proof-of-Contribution. By aggregating and validating data through Data Liquidity Pools (DLPs), Vana supports AI model training while protecting privacy and user ownership. With its focus on creating a new asset class of data tokens, Vana bridges Web2 and Web3, paving the way for a revolutionary AI-driven data economy.
Read more on VANA →